BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 38507057)

  • 1. Pan-cancer analysis of DDIT4 identifying its prognostic value and function in acute myeloid leukemia.
    Li F; Miao J; Liu R; Zhang R; He A
    J Cancer Res Clin Oncol; 2024 Mar; 150(3):144. PubMed ID: 38507057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Up-regulation of DDIT4 predicts poor prognosis in acute myeloid leukaemia.
    Cheng Z; Dai Y; Pang Y; Jiao Y; Liu Y; Cui L; Quan L; Qian T; Zeng T; Si C; Huang W; Chen J; Pang Y; Ye X; Shi J; Fu L
    J Cell Mol Med; 2020 Jan; 24(1):1067-1075. PubMed ID: 31755224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pan-cancer analysis of oncogenic TNFAIP2 identifying its prognostic value and immunological function in acute myeloid leukemia.
    Lin MS; Zhong HY; Yim RL; Chen QY; Du HL; He HQ; Lin K; Zhao P; Gao R; Gao F; Zhang MY
    BMC Cancer; 2022 Oct; 22(1):1068. PubMed ID: 36243694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of DDIT4 as a potential prognostic marker associated with chemotherapeutic and immunotherapeutic response in triple-negative breast cancer.
    Chen X; Li Z; Liang M; Zhang Z; Zhu D; Lin B; Zhou R; Lu Y
    World J Surg Oncol; 2023 Jun; 21(1):194. PubMed ID: 37391802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High expression of COMMD7 is an adverse prognostic factor in acute myeloid leukemia.
    Li K; Chen L; Zhang H; Wang L; Sha K; Du X; Li D; Zheng Z; Pei R; Lu Y; Tong H
    Aging (Albany NY); 2021 Apr; 13(8):11988-12006. PubMed ID: 33891561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DDIT4 promotes gastric cancer proliferation and tumorigenesis through the p53 and MAPK pathways.
    Du F; Sun L; Chu Y; Li T; Lei C; Wang X; Jiang M; Min Y; Lu Y; Zhao X; Nie Y; Fan D
    Cancer Commun (Lond); 2018 Jul; 38(1):45. PubMed ID: 29976242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prognostic implications and functional enrichment analysis of LTB4R in patients with acute myeloid leukemia].
    Zhang X; Zhang X; Liu P; Liu K; Li W; Chen Q; Ma W
    Nan Fang Yi Ke Da Xue Xue Bao; 2022 Mar; 42(3):309-320. PubMed ID: 35426793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The novel combination of dual mTOR inhibitor AZD2014 and pan-PIM inhibitor AZD1208 inhibits growth in acute myeloid leukemia via HSF pathway suppression.
    Harada M; Benito J; Yamamoto S; Kaur S; Arslan D; Ramirez S; Jacamo R; Platanias L; Matsushita H; Fujimura T; Kazuno S; Kojima K; Tabe Y; Konopleva M
    Oncotarget; 2015 Nov; 6(35):37930-47. PubMed ID: 26473447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA 34b inhibits cell proliferation in pediatric acute myeloid leukemia via regulating LDHA.
    Qi HX; Cao Q; Zhou GP; Sun XZ; Zhou WD; Hong Z; Hu J; Juan CX; Li S; Kuai WX
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5351-5359. PubMed ID: 31298387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA damage-inducible transcript 4 is an innate guardian for human squamous cell carcinoma and an molecular vector for anti-carcinoma effect of 1,25(OH)
    Zhang X; Luo F; Li J; Wan J; Zhang L; Li H; Chen A; Chen J; Cai T; He X; Lisse TS; Zhao H
    Exp Dermatol; 2019 Jan; 28(1):45-52. PubMed ID: 30372793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-363-3p promote the development of acute myeloid leukemia with RUNX1 mutation by targeting SPRYD4 and FNDC3B.
    Chen Y; Chen S; Lu J; Yuan D; He L; Qin P; Tan H; Xu L
    Medicine (Baltimore); 2021 May; 100(18):e25807. PubMed ID: 33950983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prognostic value of RASGEF1A RNA expression and DNA methylation in cytogenetically normal acute myeloid leukemia.
    He X; Zhang W; Fu W; Liu X; Yang P; Wang J; Zhu M; Li S; Zhang W; Zhang X; Dong G; Yan C; Zhao Y; Zeng Z; Jing H
    Cancer Biomark; 2023; 36(2):103-116. PubMed ID: 36404533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In silico evaluation of DNA Damage Inducible Transcript 4 gene (DDIT4) as prognostic biomarker in several malignancies.
    Pinto JA; Rolfo C; Raez LE; Prado A; Araujo JM; Bravo L; Fajardo W; Morante ZD; Aguilar A; Neciosup SP; Mas LA; Bretel D; Balko JM; Gomez HL
    Sci Rep; 2017 May; 7(1):1526. PubMed ID: 28484222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High NCALD expression predicts poor prognosis of cytogenetic normal acute myeloid leukemia.
    Song Y; Zhang W; He X; Liu X; Yang P; Wang J; Hu K; Liu W; Zhang X; Jing H; Yuan X
    J Transl Med; 2019 May; 17(1):166. PubMed ID: 31109331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulation of SMIM3 inhibits growth of leukemia via PI3K-AKT signaling pathway and correlates with prognosis of adult acute myeloid leukemia with normal karyotype.
    Liu Y; Chen Y; Liu Y; Li M; Zhang Y; Shi L; Yang L; Li T; Li Y; Jiang Z; Liu Y; Wang C; Wang S
    J Transl Med; 2022 Dec; 20(1):612. PubMed ID: 36550462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of long noncoding RNA HOXA-AS2 predicts an adverse prognosis and promotes tumorigenesis via SOX4/PI3K/AKT pathway in acute myeloid leukemia.
    Qu Y; Wang Y; Wang P; Lin N; Yan X; Li Y
    Cell Biol Int; 2020 Aug; 44(8):1745-1759. PubMed ID: 32369230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel scoring system for acute myeloid leukemia risk assessment based on the expression levels of six genes.
    Zhao X; Li Y; Wu H
    Int J Mol Med; 2018 Sep; 42(3):1495-1507. PubMed ID: 29956722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SPRY1 promotes cell proliferation and inhibits apoptosis by activating Hedgehog pathway in acute myeloid leukemia.
    Lv G; Wang Y; Ji C; Shi C; Li Y
    Hematology; 2022 Dec; 27(1):1-10. PubMed ID: 34957932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long non-coding RNA HOXB-AS3 promotes myeloid cell proliferation and its higher expression is an adverse prognostic marker in patients with acute myeloid leukemia and myelodysplastic syndrome.
    Huang HH; Chen FY; Chou WC; Hou HA; Ko BS; Lin CT; Tang JL; Li CC; Yao M; Tsay W; Hsu SC; Wu SJ; Chen CY; Huang SY; Tseng MH; Tien HF; Chen RH
    BMC Cancer; 2019 Jun; 19(1):617. PubMed ID: 31234830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High PD‑L1 expression drives glycolysis via an Akt/mTOR/HIF‑1α axis in acute myeloid leukemia.
    Ma P; Xing M; Han L; Gan S; Ma J; Wu F; Huang Y; Chen Y; Tian W; An C; Sun H; Sun L
    Oncol Rep; 2020 Mar; 43(3):999-1009. PubMed ID: 32020232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.